Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin system

Cancer Research

Volumn 72, Issue 19, 2012, Pages 4984-4992

  Sridharan, Vijayalakshmi ^a   Tripathi, Preeti ^a   Sharma, Sunil K ^b   Moros, Eduardo G ^d   Corry, Peter M ^b   Lieblong, Benjamin J ^b   Kaschina, Elena ^e   Unger, Thomas ^e   Thon̈e Reineke, Christa ^e   Hauer Jensen, Martin ^a,c   Boerma, Marjan ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD68 ANTIGEN; KALLIKREIN; KININ; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDITIS; CELL ASSAY; CELL COUNT; CONTROLLED STUDY; DIASTOLE; DOSE RESPONSE; ENZYME PHOSPHORYLATION; EX VIVO STUDY; GENOTYPE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART VOLUME; HISTOPATHOLOGY; IN VIVO STUDY; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RAT; SYSTOLE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD2; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOTTING, WESTERN; GENE EXPRESSION; HEART; IMMUNOHISTOCHEMISTRY; KALLIKREIN-KININ SYSTEM; KININOGENS; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIAL SWELLING; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDITIS; MYOCARDIUM; NADPH OXIDASE; PHOSPHORYLATION; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, INBRED BN; RECEPTOR, BRADYKININ B2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84867121938     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1831     Document Type: Article

References (49)

1. Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004;22:3139-48. (Pubitemid 41103728)
2. Early Breast Cancer Trialists Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000;355:1757-70.
3. Heidenreich PA, Kapoor JR. Radiation induced heart disease: systemic disorders in heart disease. Heart 2009;95:252-8.
4. Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, et al. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys 2009;75:1173-80.
5. Kole TP, Aghayere O, Kwah J, Yorke ED, Goodman KA. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer. Int J Radiat Oncol Biol Phys 2012;83:1580-6.
6. Wu WC, Chan CL, Wong YW, Cuijpers JP. A study on the in fluence of breathing phases in intensity-modulated radiotherapy of lung tumours using four-dimensional CT. Br J Radiol 2009;83:252-6.
7. Imamura T, Dubin A, Moore W, Tanaka R, Travis J. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab Invest 1996;74:861-70. (Pubitemid 26152656)
8. Coffman LG, Brown JC, Johnson DA, Parthasarathy N, D'Agostino RB Jr, Lively MO, et al. Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritin. Am J Physiol Lung Cell Mol Physiol 2008;294:L505-15. (Pubitemid 351468850)
9. Manolis AJ, Marketou ME, Gavras I, Gavras H. Cardioprotective properties of bradykinin: role of the B(2) receptor. Hypertens Res 2010;33:772-7.
10. Spillmann F, Altmann C, Scheeler M, Barbosa M, Westermann D, Schultheiss HP, et al. Regulation of cardiac bradykinin B1-and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy. Int Immunopharmacol 2002;2:1823-32. (Pubitemid 35373923)
11. Agata J, Chao L, Chao J. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension 2002;40:653-9. (Pubitemid 35278601)
12. Sun D, Shen M, Li J, Li W, Zhang Y, Zhao L, et al. Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3beta dependent pathway in experimental diabetic cardiomyopathy. Cardiovasc Diabetol 2011;10:4.
13. Koike MK, de Carvalho FC, de Lourdes HM. Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats. Clin Exp Pharmacol Physiol 2005;32:1131-6. (Pubitemid 43906825)
14. Kim NN, Villegas S, Summerour SR, Villarreal FJ. Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide. J Mol Cell Cardiol 1999;31:457-66. (Pubitemid 29089893)
15. Yin H, Chao L, Chao J. Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion. Life Sci 2008;82:156-65.
16. Damas J. The brown Norway rats and the kinin system. Peptides 1996;17:859-72. (Pubitemid 26258617)
17. Kaschina E, Stoll M, Sommerfeld M, Steckelings UM, Kreutz R, Unger T. Genetic kininogen deficiency contributes to aortic aneurysm formation but not to atherosclerosis. Physiol Genomics 2004;19:41-9. (Pubitemid 40039912)
18. Koch M, Bonaventura K, Spillmann F, Dendorfer A, Schultheiss HP, Tschope C. Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model. Biol Chem 2008;389:719-23. (Pubitemid 352009416)
19. Liu YH, Yang XP, Mehta D, Bulagannawar M, Scicli GM, Carretero OA. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats. Am J Physiol Heart Circ Physiol 2000;278:H507-14. (Pubitemid 30131251)
20. Van Luijk P, Faber H, Meertens H, Schippers JM, Langendijk JA, Brandenburg S, et al. The impact of heart irradiation on dose-volume effects in the rat lung. Int J Radiat Oncol Biol Phys 2007;69:552-9. (Pubitemid 47385947)
21. Huang EX, Hope AJ, Lindsay PE, Trovo M, El N I, Deasy JO, et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 2011;50:51-60.
22. Hayashi I, Oh-ishi S. Plasma kininogen deficiency: associated defective secretion of kininogens by primary cultures of hepatocytes from brown Norway Katholiek rats. J Biochem 1993;113:531-7. (Pubitemid 23166980)
23. Damas J, Adam A. Congenital deficiency in plasma kallikrein and kininogens in the brown Norway rat. Experientia 1980;36:586-7. (Pubitemid 10038206)
24. Devic S, Seuntjens J, Sham E, Podgorsak EB, Schmidtlein CR, Kirov AS, et al. Precise radiochromic film dosimetry using a flat-bed document scanner. Med Phys 2005;32:2245-53. (Pubitemid 41023182)
25. Bauer M, Cheng S, Jain M, Ngoy S, Theodoropoulos C, Trujillo A, et al. Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice. Circ Res 2011;108:908-16.
26. Boerma M, Wang J, Wondergem J, Joseph J, Qiu X, Kennedy RH, et al. Influence of mast cells on structural and functional manifestations of radiation-induced heart disease. Cancer Res 2005;65:3100-7. (Pubitemid 40524590)
27. Ito H, Hayashi I, Izumi T, Majima M. Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats. Br J Pharmacol 2003;138:225-33. (Pubitemid 36194224)
28. Shukla J, Khan NM, Thakur VS, Poduval TB. L-arginine mitigates radiation-induced early changes in cardiac dysfunction: the role of inflammatory pathways. Radiat Res 2011;176:158-69.
29. Levesque L, Lam MH, Allaire P, Mondat M, Houle S, Beaudoin G, et al. Effects of radiation therapy on vascular responsiveness. J Cardiovasc Pharmacol 2001;37:381-93. (Pubitemid 32240420)
30. Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versusdemons in a heart-breaking tale. Physiol Rev 2010;90:1507-46.
31. Yan JT, Wang T, Wang DW. Recombinant adeno-associated virus-mediated human kallikrein gene therapy protects against hypertensive target organ injuries through inhibiting cell apoptosis. Acta Pharmacol Sin 2009;30:1253-61.
32. Feinberg MW, Shimizu K, Lebedeva M, Haspel R, Takayama K, Chen Z, et al. Essential role for smad3 in regulating MCP-1 expression and vascular inflammation. Circ Res 2004;94:601-8. (Pubitemid 38387742)
33. Erven K, Jurcut R, Weltens C, Giusca S, Ector J, Wildiers H, et al. Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients. Int J Radiat Oncol Biol Phys 2011;79:1444-51.
34. Woodfin A, Hu DE, Sarker M, Kurokawa T, Fraser P. Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia-reperfusion. Free Radic Biol Med 2011;50:518-24.
35. Dias JP, Talbot S, Senecal J, Carayon P, Couture R. Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications. PLoS One 2010;5:e12622.
36. Nabeebaccus A, Zhang M, Shah AM. NADPH oxidases and cardiac remodelling. Heart Fail Rev 2011;16:5-12.
37. Wang Y, Liu L, Pazhanisamy SK, Li H, Meng A, Zhou D. Total body irradiation causes residual bone marrow injury by induction of persistent oxidative stress in murine hematopoietic stem cells. Free Radic Biol Med 2010;48:348-56.
38. Zhang P, Hou M, Li Y, Xu X, Barsoum M, Chen Y, et al. NADPH oxidase contributes to coronary endothelial dysfunction in the failing heart. Am J Physiol Heart Circ Physiol 2009;296:H840-6.
39. Zhao Y, McLaughlin D, Robinson E, Harvey AP, Hookham MB, Shah AM, et al. Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy. Cancer Res 2010;70:9287-97.
40. Craige SM, Chen K, Pei Y, Li C, Huang X, Chen C, et al. NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 2011;124:731-40.
41. Di Lisa F, Carpi A, Giorgio V, Bernardi P. The mitochondrial permeability transition pore and cyclophilin D in cardioprotection. Biochim Biophys Acta 2011;1813:1316-22.
42. Barjaktarovic Z, Schmaltz D, Shyla A, Azimzadeh O, Schulz S, Haagen J, et al. Radiation-induced signaling results in mitochondrial impairment in mouse heart at 4 weeks after exposure to X-rays. PLoS One 2011;6:e27811.
43. Imaizumi N, Aniya Y. The role of a membrane-bound glutathione transferase in the peroxynitrite-induced mitochondrial permeability transition pore: formation of a disul fide-linked protein complex. Arch Biochem Biophys 2011;516:160-72.
44. Park SS, Zhao H, Mueller RA, Xu Z. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. J Mol Cell Cardiol 2006;40:708-16.
45. Bockmann S, Paegelow I. Kinins and kinin receptors: importance for the activation of leukocytes. J Leukoc Biol 2000;68:587-92.
46. Jiang B, Liao R. The paradoxical role of inflammation in cardiac repair and regeneration. J Cardiovasc Transl Res 2010;3:410-6.
47. Wei CC, Hase N, Inoue Y, Bradley EW, Yahiro E, Li M, et al. Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents. J Clin Invest 2010;120:1229-39.
48. Fleming I. Signaling by the angiotensin-converting enzyme. Circ Res 2006;98:887-96.
49. Marketou M, Kintsurashvili E, Papanicolaou KN, Lucero HA, Gavras I, Gavras H. Cardioprotective effects of a selective B(2) receptor agonist of bradykinin post-acute myocardial infarct. Am J Hypertens 2010;23:562-8.